UK Field Epidemiology Training Programme, Public Health England, London, United Kingdom.
North West Field Services, National Infection Service, Public Health England, Liverpool, United Kingdom.
Influenza Other Respir Viruses. 2021 May;15(3):336-344. doi: 10.1111/irv.12846. Epub 2021 Mar 1.
Knowledge gaps remain regarding SARS-CoV-2 transmission on flights. We conducted a retrospective cohort study to estimate risk of acquiring symptomatic SARS-CoV-2 on aircraft, to inform contact tracing and infection control efforts.
We identified co-passengers of infectious passengers on 18 England-bound flights from European cities up to 12/03/2020, using manifests received for contact tracing. Infectious passengers were laboratory-confirmed cases with symptom onset from 7 days before to 2 days after the flight. Possible aircraft-acquired cases were laboratory-confirmed with onset 3-14 days post-flight with no known non-flight exposure. Manifests was merged with the national case management dataset (identifying cases, onset dates, contact tracing status) and the national COVID-19 linelist. Contact tracing notes were reviewed to identify non-flight exposures. We calculated attack rates (ARs) among all co-passengers and within subgroups, including by distance from infectious cases and number of infectious cases on-board.
There were 55 infectious passengers and 2313 co-passengers, including 2221 flight-only contacts. Five possible aircraft-acquired cases were identified; ARs of 0.2% (95%CI 0.1-0.5) among all flight-only contacts and 3.8% (95%CI 1.3-10.6) among contact-traced flight-only contacts sat within a two-seat radius. The AR among 92 co-travellers with known non-flight exposure to infectious cases was 13.0% (95%CI 7.6%-21.4%). There were insufficient numbers to assess differences between subgroups.
We conclude that risk of symptomatic COVID-19 due to transmission on short to medium-haul flights is low, and recommend prioritising contact-tracing of close contacts and co-travellers where resources are limited. Further research on risk on aircraft is encouraged.
关于 SARS-CoV-2 在航班上传播的知识空白仍然存在。我们进行了一项回顾性队列研究,以估计在飞机上感染 SARS-CoV-2 的症状的风险,为接触者追踪和感染控制工作提供信息。
我们使用接触者追踪收到的清单,确定了 18 架从欧洲城市飞往英国的航班上传染性乘客的同机乘客。传染性乘客是指有症状的实验室确诊病例,症状发作时间在航班前 7 天至航班后 2 天内。可能在飞机上感染的病例是在航班后 3-14 天内发病且无已知非航班暴露的实验室确诊病例。清单与国家病例管理数据集(识别病例、发病日期、接触者追踪状态)和国家 COVID-19 清单合并。审查接触者追踪记录以确定非航班暴露情况。我们计算了所有同机乘客和亚组(包括距传染性病例的距离和机上传染性病例数)的发病率(AR)。
共有 55 名传染性乘客和 2313 名同机乘客,包括 2221 名仅飞行接触者。共发现 5 例可能在飞机上感染的病例;仅飞行接触者的发病率为 0.2%(95%CI 0.1-0.5),接受接触者追踪的仅飞行接触者的发病率为 3.8%(95%CI 1.3-10.6),位于两个座位半径内。已知与传染性病例有非飞行接触的 92 名同行旅行者的发病率为 13.0%(95%CI 7.6%-21.4%)。没有足够的数量来评估亚组之间的差异。
我们得出的结论是,在短途和中程航班上因传播而导致有症状的 COVID-19 的风险较低,并建议在资源有限的情况下优先对密切接触者和同行旅行者进行接触者追踪。鼓励进一步研究飞机上的风险。